---
title: Pharmacovigilance & Drug Safety CROs in United States
path: /services/pharmacovigilance/us
companies_count: 18
---

# Pharmacovigilance & Drug Safety CROs in United States

18 published CROs match Pharmacovigilance & Drug Safety in United States.

Locations in this set include United States, United Kingdom, India, Australia, France, and Germany.

Capabilities that show up most often in this set: Vaccine, Biologics (Other), Cell Therapy, Gene Therapy, and Small Molecule.

## Matching companies

- [Clarenta](/companies/comac-medical)
  - Clarenta (formerly Comac Medical Group) is a pan-European CRO offering full-service trial delivery and early-phase studies, including first-in-human and PK work. It runs a Phase I unit in Sofia and has depth in oncology and rare diseases.
- [ERGOMED Group](/companies/ergomed)
  - Global, full-service CRO specializing in oncology and rare disease clinical development, with complementary pharmacovigilance and QA consulting brands.
- [Emerald Clinical](/companies/emeraldclinical)
  - Global clinical research organization with 25+ years of expertise, headquartered in Singapore with operations across Asia-Pacific, EMEA, and the Americas. Specializes in renal, oncology, cardiovascular, and early-phase research with deep scientific leadership and proven operational excellence.
- [ExperTrials](/companies/expertrials)
  - European-based full-service CRO supporting biotech and medtech companies from Phase I through Phase IV and market access, with 80+ senior clinical research associates across Europe and the USA.
- [Fortrea](/companies/fortrea)
  - Fortrea is a leading CRO advancing clinical trials through patient-focused clinical solutions that accelerate clinical development and drive trial success.
- [ICON plc](/companies/iconplc)
  - ICON is a global clinical research organization providing full-service drug development and clinical trial solutions across early phase through post-marketing, including clinical operations, bioanalytical labs, cardiac safety, medical imaging, and regulatory affairs.
- [Medpace](/companies/medpace)
  - Full-service CRO with 30+ years of organic growth, offering integrated clinical development services across all phases with wholly-owned central labs, bioanalytical lab, imaging core lab, and Phase I unit.
- [PPD](/companies/ppd)
  - PPD is a leading global contract research organization (CRO) and the clinical research business of Thermo Fisher Scientific.
- [Pharmaron](/companies/pharmaron)
  - Premier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.
- [Premier Research](/companies/premier-research)
  - Premier Research is a global full-service CRO delivering clinical research and development solutions across the complete drug development lifecycle. The organization provides comprehensive capabilities spanning study design, study startup, medical affairs, biostatistics and data management, central monitoring, clinical monitoring and site management, project and risk management, safety and pharmacovigilance, quality and compliance, and medical writing.
- [PrimeVigilance](/companies/primevigilance)
  - Pharmacovigilance and safety services provider offering end-to-end operations, technology-driven solutions, and specialized expertise in vaccines, CGT/ATMP, pediatric medicines, and geriatric populations.
- [ProRelix Research](/companies/prorelixresearch)
  - ProRelix Research supports Phase 1–4 clinical trials across pharmaceutical, biotechnology, and medical device sectors, offering clinical trial project management, data management, and medical writing services in compliance with ICH and GCP principles across the US, India, Europe, and Australia.
- [QPS](/companies/qps)
  - QPS provides integrated contract research and clinical services spanning bioanalysis, preclinical development, and early-to-late phase clinical trials across multiple therapeutic areas including oncology, dermatology, and women's health.
- [Quanticate](/companies/quanticate)
  - Quanticate is a biometrics CRO with 30 years of expertise in biostatistics, clinical data management, and pharmacovigilance across all clinical trial phases. The company specializes in statistical protocol design, CDISC standards compliance, and real-world data analysis to support regulatory submissions.
- [Sofpromed](/companies/sofpromed)
  - Full-service CRO specializing in Phase I–IV clinical trials across oncology, cardiovascular, metabolic, CNS, dermatological, infectious, and respiratory diseases, with global trial management capabilities and expertise in rare tumor research.
- [Syneos Health](/companies/syneoshealth)
  - Global CRO with 26,000+ employees offering integrated clinical development, regulatory affairs, and commercialization services. Helped develop or commercialize 96% of FDA-approved oncology drugs and 93% of EMA-authorized oncology products in the last five years.
- [Syngene International](/companies/syngeneintl)
  - Innovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.
- [TFS HealthScience](/companies/tfscro)
  - Global mid-size CRO specializing in dermatology, internal medicine, neuroscience, oncology, and ophthalmology with Phase I-IV clinical development, real-world evidence studies, and flexible resourcing solutions across 600+ experts in Europe, North America, and Australia.
